This discovery broadens the therapeutic horizon for HCC by suggesting potential synergistic effects between dihydroartemisinin and AIM2-mediated pathways in fostering cellular self-digestion, a process known to counteract tumorigenesis. The gene discussed is AIM2; the disease is hepatocellular carcinoma.